EUVIMEDEUVIMED entdecken
Crossref

Exploring New Imines as Anti-Inflammatory COX and 5-LOX Inhibitors with an Improved Pharmacokinetic Profile

Mona F Said iD, Bahia A Moussa, Marianne A Mahrouse iD, Sarah M Marie, Nada M Mohamed iD

Future Medicinal Chemistry · 2024

DOI: 10.4155/fmc-2023-0280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2024. Verfasst von Mona F Said und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, PO Box 11562, Egypt. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Anti-Inflammatory Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dual COX/5-LOX inhibition is a bright strategy for developing new potent and safe anti-inflammatory agents.

Methods

New imines were synthesized and evaluated for their anti-inflammatory activity. The most active compounds were further investigated for their safety profile. Their molecular docking and physicochemical parameters were assessed. A new LC-MS/MS method was developed for the quantification of compound 4d in rat plasma.

Results

Synthesized compounds were found to have anti-inflammatory activity (77-88% edema inhibition). In addition, 4d, 5m and 7d showed analgesic activity (92.50, 95.71 and 96.28% protection, respectively). 4d showed dual COX-2/5-LOX activity. Molecular docking expected the binding pattern of compounds in COX-1, COX-2 and 5-LOX active sites. The in vivo pharmacokinetic parameters of compound 4d were also obtained.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryAnti-Inflammatory AgentsRatsAnimalsCyclooxygenase 2Molecular Docking SimulationChromatography, LiquidEdemaLipoxygenase InhibitorsCyclooxygenase 2 InhibitorsStructure-Activity RelationshipAnti-Inflammatory Agents, Non-SteroidalMolecular Structure

Stichwörter der Autor:innen

COX inhibitorsNSAIDsanti-inflammatorydual COX/5-LOX inhibitorsoxindole

Substanzen

Cyclooxygenase 2Anti-Inflammatory AgentsLipoxygenase InhibitorsCyclooxygenase 2 InhibitorsAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, PO Box 11562, Egypt.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Modern University for Technology & Information MTI, Cairo, Egypt.

ORCID-Profile: Mona F Said, Marianne A Mahrouse, Nada M Mohamed

Zitieren

APA

Said, M. F., Moussa, B. A., Mahrouse, M. A., Marie, S. M., & Mohamed, N. M. (2024). Exploring New Imines as Anti-Inflammatory COX and 5-LOX Inhibitors with an Improved Pharmacokinetic Profile. Future Medicinal Chemistry. https://doi.org/10.4155/fmc-2023-0280

Vancouver

Said MF, Moussa BA, Mahrouse MA, Marie SM, Mohamed NM. Exploring New Imines as Anti-Inflammatory COX and 5-LOX Inhibitors with an Improved Pharmacokinetic Profile. Future Medicinal Chemistry. 2024. doi:10.4155/fmc-2023-0280

BibTeX
@article{Said2024,
  author = {Said, Mona F and Moussa, Bahia A and Mahrouse, Marianne A and Marie, Sarah M and Mohamed, Nada M},
  title = {Exploring New Imines as Anti-Inflammatory COX and 5-LOX Inhibitors with an Improved Pharmacokinetic Profile},
  journal = {Future Medicinal Chemistry},
  year = {2024},
  doi = {10.4155/fmc-2023-0280}
}
Kostenlos starten →